Pharma & Healthcare
Global Antisense Oligonucleotides Drugs for ATTR Market Research Report 2026
- Mar 17, 26
- ID: 741385
- Pages: 93
- Figures: 107
- Views: 2
This report delivers a comprehensive overview of the global Antisense Oligonucleotides Drugs for ATTR market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Antisense Oligonucleotides Drugs for ATTR. The Antisense Oligonucleotides Drugs for ATTR market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Antisense Oligonucleotides Drugs for ATTR market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Antisense Oligonucleotides Drugs for ATTR manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Akcea Therapeutics
AstraZeneca
Ionis Pharmaceuticals
Segment by Type
Inotersen
Eplontersen
Other
by Application
Hospital and Clinic
Retail Pharmacies
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Antisense Oligonucleotides Drugs for ATTR manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Antisense Oligonucleotides Drugs for ATTR sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Antisense Oligonucleotides Drugs for ATTR market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Antisense Oligonucleotides Drugs for ATTR manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Akcea Therapeutics
AstraZeneca
Ionis Pharmaceuticals
Segment by Type
Inotersen
Eplontersen
Other
by Application
Hospital and Clinic
Retail Pharmacies
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Antisense Oligonucleotides Drugs for ATTR manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Antisense Oligonucleotides Drugs for ATTR sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Antisense Oligonucleotides Drugs for ATTR Market Overview
1.1 Product Definition
1.2 Antisense Oligonucleotides Drugs for ATTR by Type
1.2.1 Global Antisense Oligonucleotides Drugs for ATTR Market Value by Type: 2025 vs 2032
1.2.2 Inotersen
1.2.3 Eplontersen
1.2.4 Other
1.3 Antisense Oligonucleotides Drugs for ATTR by Application
1.3.1 Global Antisense Oligonucleotides Drugs for ATTR Market Value by Application: 2025 vs 2032
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Global Antisense Oligonucleotides Drugs for ATTR Market Size Estimates and Forecasts
1.4.1 Global Antisense Oligonucleotides Drugs for ATTR Revenue 2021–2032
1.4.2 Global Antisense Oligonucleotides Drugs for ATTR Sales 2021–2032
1.4.3 Global Antisense Oligonucleotides Drugs for ATTR Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Antisense Oligonucleotides Drugs for ATTR Market Competition by Manufacturers
2.1 Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Manufacturers (2021–2026)
2.2 Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Antisense Oligonucleotides Drugs for ATTR Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Antisense Oligonucleotides Drugs for ATTR, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Antisense Oligonucleotides Drugs for ATTR, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Antisense Oligonucleotides Drugs for ATTR, Product Types and Applications
2.7 Global Key Manufacturers of Antisense Oligonucleotides Drugs for ATTR, Date of Entry into the Industry
2.8 Global Antisense Oligonucleotides Drugs for ATTR Market Competitive Situation and Trends
2.8.1 Global Antisense Oligonucleotides Drugs for ATTR Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Antisense Oligonucleotides Drugs for ATTR Players Market Share by Revenue
2.8.3 Global Antisense Oligonucleotides Drugs for ATTR Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antisense Oligonucleotides Drugs for ATTR Market Scenario by Region
3.1 Global Antisense Oligonucleotides Drugs for ATTR Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Antisense Oligonucleotides Drugs for ATTR Sales by Region: 2021–2032
3.2.1 Global Antisense Oligonucleotides Drugs for ATTR Sales by Region: 2021–2026
3.2.2 Global Antisense Oligonucleotides Drugs for ATTR Sales by Region: 2027–2032
3.3 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Region: 2021–2032
3.3.1 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Region: 2021–2026
3.3.2 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Region: 2027–2032
3.4 North America Antisense Oligonucleotides Drugs for ATTR Market Facts & Figures by Country
3.4.1 North America Antisense Oligonucleotides Drugs for ATTR Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Antisense Oligonucleotides Drugs for ATTR Sales by Country (2021–2032)
3.4.3 North America Antisense Oligonucleotides Drugs for ATTR Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antisense Oligonucleotides Drugs for ATTR Market Facts & Figures by Country
3.5.1 Europe Antisense Oligonucleotides Drugs for ATTR Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Antisense Oligonucleotides Drugs for ATTR Sales by Country (2021–2032)
3.5.3 Europe Antisense Oligonucleotides Drugs for ATTR Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antisense Oligonucleotides Drugs for ATTR Market Facts & Figures by Region
3.6.1 Asia Pacific Antisense Oligonucleotides Drugs for ATTR Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Antisense Oligonucleotides Drugs for ATTR Sales by Region (2021–2032)
3.6.3 Asia Pacific Antisense Oligonucleotides Drugs for ATTR Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Antisense Oligonucleotides Drugs for ATTR Market Facts & Figures by Country
3.7.1 Latin America Antisense Oligonucleotides Drugs for ATTR Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Antisense Oligonucleotides Drugs for ATTR Sales by Country (2021–2032)
3.7.3 Latin America Antisense Oligonucleotides Drugs for ATTR Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Market Facts & Figures by Country
3.8.1 Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Sales by Country (2021–2032)
3.8.3 Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antisense Oligonucleotides Drugs for ATTR Sales by Type (2021–2032)
4.1.1 Global Antisense Oligonucleotides Drugs for ATTR Sales by Type (2021–2026)
4.1.2 Global Antisense Oligonucleotides Drugs for ATTR Sales by Type (2027–2032)
4.1.3 Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Type (2021–2032)
4.2 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Type (2021–2032)
4.2.1 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Type (2021–2026)
4.2.2 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Type (2027–2032)
4.2.3 Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Type (2021–2032)
4.3 Global Antisense Oligonucleotides Drugs for ATTR Price by Type (2021–2032)
5 Segment by Application
5.1 Global Antisense Oligonucleotides Drugs for ATTR Sales by Application (2021–2032)
5.1.1 Global Antisense Oligonucleotides Drugs for ATTR Sales by Application (2021–2026)
5.1.2 Global Antisense Oligonucleotides Drugs for ATTR Sales by Application (2027–2032)
5.1.3 Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Application (2021–2032)
5.2 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Application (2021–2032)
5.2.1 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Application (2021–2026)
5.2.2 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Application (2027–2032)
5.2.3 Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Application (2021–2032)
5.3 Global Antisense Oligonucleotides Drugs for ATTR Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Akcea Therapeutics
6.1.1 Akcea Therapeutics Company Information
6.1.2 Akcea Therapeutics Description and Business Overview
6.1.3 Akcea Therapeutics Antisense Oligonucleotides Drugs for ATTR Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Akcea Therapeutics Antisense Oligonucleotides Drugs for ATTR Product Portfolio
6.1.5 Akcea Therapeutics Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Antisense Oligonucleotides Drugs for ATTR Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 AstraZeneca Antisense Oligonucleotides Drugs for ATTR Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Ionis Pharmaceuticals
6.3.1 Ionis Pharmaceuticals Company Information
6.3.2 Ionis Pharmaceuticals Description and Business Overview
6.3.3 Ionis Pharmaceuticals Antisense Oligonucleotides Drugs for ATTR Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Ionis Pharmaceuticals Antisense Oligonucleotides Drugs for ATTR Product Portfolio
6.3.5 Ionis Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antisense Oligonucleotides Drugs for ATTR Industry Chain Analysis
7.2 Antisense Oligonucleotides Drugs for ATTR Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antisense Oligonucleotides Drugs for ATTR Production Mode & Process Analysis
7.4 Antisense Oligonucleotides Drugs for ATTR Sales and Marketing
7.4.1 Antisense Oligonucleotides Drugs for ATTR Sales Channels
7.4.2 Antisense Oligonucleotides Drugs for ATTR Distributors
7.5 Antisense Oligonucleotides Drugs for ATTR Customer Analysis
8 Antisense Oligonucleotides Drugs for ATTR Market Dynamics
8.1 Antisense Oligonucleotides Drugs for ATTR Industry Trends
8.2 Antisense Oligonucleotides Drugs for ATTR Market Drivers
8.3 Antisense Oligonucleotides Drugs for ATTR Market Challenges
8.4 Antisense Oligonucleotides Drugs for ATTR Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Antisense Oligonucleotides Drugs for ATTR by Type
1.2.1 Global Antisense Oligonucleotides Drugs for ATTR Market Value by Type: 2025 vs 2032
1.2.2 Inotersen
1.2.3 Eplontersen
1.2.4 Other
1.3 Antisense Oligonucleotides Drugs for ATTR by Application
1.3.1 Global Antisense Oligonucleotides Drugs for ATTR Market Value by Application: 2025 vs 2032
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Global Antisense Oligonucleotides Drugs for ATTR Market Size Estimates and Forecasts
1.4.1 Global Antisense Oligonucleotides Drugs for ATTR Revenue 2021–2032
1.4.2 Global Antisense Oligonucleotides Drugs for ATTR Sales 2021–2032
1.4.3 Global Antisense Oligonucleotides Drugs for ATTR Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Antisense Oligonucleotides Drugs for ATTR Market Competition by Manufacturers
2.1 Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Manufacturers (2021–2026)
2.2 Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Antisense Oligonucleotides Drugs for ATTR Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Antisense Oligonucleotides Drugs for ATTR, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Antisense Oligonucleotides Drugs for ATTR, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Antisense Oligonucleotides Drugs for ATTR, Product Types and Applications
2.7 Global Key Manufacturers of Antisense Oligonucleotides Drugs for ATTR, Date of Entry into the Industry
2.8 Global Antisense Oligonucleotides Drugs for ATTR Market Competitive Situation and Trends
2.8.1 Global Antisense Oligonucleotides Drugs for ATTR Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Antisense Oligonucleotides Drugs for ATTR Players Market Share by Revenue
2.8.3 Global Antisense Oligonucleotides Drugs for ATTR Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antisense Oligonucleotides Drugs for ATTR Market Scenario by Region
3.1 Global Antisense Oligonucleotides Drugs for ATTR Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Antisense Oligonucleotides Drugs for ATTR Sales by Region: 2021–2032
3.2.1 Global Antisense Oligonucleotides Drugs for ATTR Sales by Region: 2021–2026
3.2.2 Global Antisense Oligonucleotides Drugs for ATTR Sales by Region: 2027–2032
3.3 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Region: 2021–2032
3.3.1 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Region: 2021–2026
3.3.2 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Region: 2027–2032
3.4 North America Antisense Oligonucleotides Drugs for ATTR Market Facts & Figures by Country
3.4.1 North America Antisense Oligonucleotides Drugs for ATTR Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Antisense Oligonucleotides Drugs for ATTR Sales by Country (2021–2032)
3.4.3 North America Antisense Oligonucleotides Drugs for ATTR Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antisense Oligonucleotides Drugs for ATTR Market Facts & Figures by Country
3.5.1 Europe Antisense Oligonucleotides Drugs for ATTR Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Antisense Oligonucleotides Drugs for ATTR Sales by Country (2021–2032)
3.5.3 Europe Antisense Oligonucleotides Drugs for ATTR Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antisense Oligonucleotides Drugs for ATTR Market Facts & Figures by Region
3.6.1 Asia Pacific Antisense Oligonucleotides Drugs for ATTR Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Antisense Oligonucleotides Drugs for ATTR Sales by Region (2021–2032)
3.6.3 Asia Pacific Antisense Oligonucleotides Drugs for ATTR Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Antisense Oligonucleotides Drugs for ATTR Market Facts & Figures by Country
3.7.1 Latin America Antisense Oligonucleotides Drugs for ATTR Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Antisense Oligonucleotides Drugs for ATTR Sales by Country (2021–2032)
3.7.3 Latin America Antisense Oligonucleotides Drugs for ATTR Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Market Facts & Figures by Country
3.8.1 Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Sales by Country (2021–2032)
3.8.3 Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antisense Oligonucleotides Drugs for ATTR Sales by Type (2021–2032)
4.1.1 Global Antisense Oligonucleotides Drugs for ATTR Sales by Type (2021–2026)
4.1.2 Global Antisense Oligonucleotides Drugs for ATTR Sales by Type (2027–2032)
4.1.3 Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Type (2021–2032)
4.2 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Type (2021–2032)
4.2.1 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Type (2021–2026)
4.2.2 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Type (2027–2032)
4.2.3 Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Type (2021–2032)
4.3 Global Antisense Oligonucleotides Drugs for ATTR Price by Type (2021–2032)
5 Segment by Application
5.1 Global Antisense Oligonucleotides Drugs for ATTR Sales by Application (2021–2032)
5.1.1 Global Antisense Oligonucleotides Drugs for ATTR Sales by Application (2021–2026)
5.1.2 Global Antisense Oligonucleotides Drugs for ATTR Sales by Application (2027–2032)
5.1.3 Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Application (2021–2032)
5.2 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Application (2021–2032)
5.2.1 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Application (2021–2026)
5.2.2 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Application (2027–2032)
5.2.3 Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Application (2021–2032)
5.3 Global Antisense Oligonucleotides Drugs for ATTR Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Akcea Therapeutics
6.1.1 Akcea Therapeutics Company Information
6.1.2 Akcea Therapeutics Description and Business Overview
6.1.3 Akcea Therapeutics Antisense Oligonucleotides Drugs for ATTR Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Akcea Therapeutics Antisense Oligonucleotides Drugs for ATTR Product Portfolio
6.1.5 Akcea Therapeutics Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Antisense Oligonucleotides Drugs for ATTR Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 AstraZeneca Antisense Oligonucleotides Drugs for ATTR Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Ionis Pharmaceuticals
6.3.1 Ionis Pharmaceuticals Company Information
6.3.2 Ionis Pharmaceuticals Description and Business Overview
6.3.3 Ionis Pharmaceuticals Antisense Oligonucleotides Drugs for ATTR Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Ionis Pharmaceuticals Antisense Oligonucleotides Drugs for ATTR Product Portfolio
6.3.5 Ionis Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antisense Oligonucleotides Drugs for ATTR Industry Chain Analysis
7.2 Antisense Oligonucleotides Drugs for ATTR Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antisense Oligonucleotides Drugs for ATTR Production Mode & Process Analysis
7.4 Antisense Oligonucleotides Drugs for ATTR Sales and Marketing
7.4.1 Antisense Oligonucleotides Drugs for ATTR Sales Channels
7.4.2 Antisense Oligonucleotides Drugs for ATTR Distributors
7.5 Antisense Oligonucleotides Drugs for ATTR Customer Analysis
8 Antisense Oligonucleotides Drugs for ATTR Market Dynamics
8.1 Antisense Oligonucleotides Drugs for ATTR Industry Trends
8.2 Antisense Oligonucleotides Drugs for ATTR Market Drivers
8.3 Antisense Oligonucleotides Drugs for ATTR Market Challenges
8.4 Antisense Oligonucleotides Drugs for ATTR Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Antisense Oligonucleotides Drugs for ATTR Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Antisense Oligonucleotides Drugs for ATTR Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Antisense Oligonucleotides Drugs for ATTR Market Competitive Situation by Manufacturers in 2025
Table 4. Global Antisense Oligonucleotides Drugs for ATTR Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Antisense Oligonucleotides Drugs for ATTR Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Antisense Oligonucleotides Drugs for ATTR Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Antisense Oligonucleotides Drugs for ATTR Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Antisense Oligonucleotides Drugs for ATTR, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Antisense Oligonucleotides Drugs for ATTR, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Antisense Oligonucleotides Drugs for ATTR, Product Types and Applications
Table 12. Global Key Manufacturers of Antisense Oligonucleotides Drugs for ATTR, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antisense Oligonucleotides Drugs for ATTR Companies by Tier (Tier 1, Tier 2, Tier 3), based on Antisense Oligonucleotides Drugs for ATTR Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antisense Oligonucleotides Drugs for ATTR Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Antisense Oligonucleotides Drugs for ATTR Sales by Region (K Units), 2021–2026
Table 18. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Region (2021–2026)
Table 19. Global Antisense Oligonucleotides Drugs for ATTR Sales by Region (K Units), 2027–2032
Table 20. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Region (2027–2032)
Table 21. Global Antisense Oligonucleotides Drugs for ATTR Revenue by Region (US$ Million), 2021–2026
Table 22. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Region (2021–2026)
Table 23. Global Antisense Oligonucleotides Drugs for ATTR Revenue by Region (US$ Million), 2027–2032
Table 24. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Region (2027–2032)
Table 25. North America Antisense Oligonucleotides Drugs for ATTR Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2021–2026
Table 27. North America Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2027–2032
Table 28. North America Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2021–2026
Table 29. North America Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Antisense Oligonucleotides Drugs for ATTR Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2021–2026
Table 32. Europe Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2027–2032
Table 33. Europe Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Antisense Oligonucleotides Drugs for ATTR Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2021–2026
Table 42. Latin America Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2027–2032
Table 43. Latin America Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2027–2032
Table 50. Global Antisense Oligonucleotides Drugs for ATTR Sales (K Units) by Type (2021–2026)
Table 51. Global Antisense Oligonucleotides Drugs for ATTR Sales (K Units) by Type (2027–2032)
Table 52. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Type (2021–2026)
Table 53. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Type (2027–2032)
Table 54. Global Antisense Oligonucleotides Drugs for ATTR Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Antisense Oligonucleotides Drugs for ATTR Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Type (2021–2026)
Table 57. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Type (2027–2032)
Table 58. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Type (2021–2026)
Table 59. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Type (2027–2032)
Table 60. Global Antisense Oligonucleotides Drugs for ATTR Sales (K Units) by Application (2021–2026)
Table 61. Global Antisense Oligonucleotides Drugs for ATTR Sales (K Units) by Application (2027–2032)
Table 62. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Application (2021–2026)
Table 63. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Application (2027–2032)
Table 64. Global Antisense Oligonucleotides Drugs for ATTR Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Antisense Oligonucleotides Drugs for ATTR Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Application (2021–2026)
Table 67. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Application (2027–2032)
Table 68. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Application (2021–2026)
Table 69. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Application (2027–2032)
Table 70. Akcea Therapeutics Company Information
Table 71. Akcea Therapeutics Description and Business Overview
Table 72. Akcea Therapeutics Antisense Oligonucleotides Drugs for ATTR Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Akcea Therapeutics Antisense Oligonucleotides Drugs for ATTR Product
Table 74. Akcea Therapeutics Recent Developments/Updates
Table 75. AstraZeneca Company Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Antisense Oligonucleotides Drugs for ATTR Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. AstraZeneca Antisense Oligonucleotides Drugs for ATTR Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Ionis Pharmaceuticals Company Information
Table 81. Ionis Pharmaceuticals Description and Business Overview
Table 82. Ionis Pharmaceuticals Antisense Oligonucleotides Drugs for ATTR Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Ionis Pharmaceuticals Antisense Oligonucleotides Drugs for ATTR Product
Table 84. Ionis Pharmaceuticals Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Antisense Oligonucleotides Drugs for ATTR Distributors List
Table 88. Antisense Oligonucleotides Drugs for ATTR Customers List
Table 89. Antisense Oligonucleotides Drugs for ATTR Market Trends
Table 90. Antisense Oligonucleotides Drugs for ATTR Market Drivers
Table 91. Antisense Oligonucleotides Drugs for ATTR Market Challenges
Table 92. Antisense Oligonucleotides Drugs for ATTR Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Product Picture of Antisense Oligonucleotides Drugs for ATTR
Figure 2. Global Antisense Oligonucleotides Drugs for ATTR Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Antisense Oligonucleotides Drugs for ATTR Market Share by Type: 2025 & 2032
Figure 4. Inotersen Product Picture
Figure 5. Eplontersen Product Picture
Figure 6. Other Product Picture
Figure 7. Global Antisense Oligonucleotides Drugs for ATTR Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Antisense Oligonucleotides Drugs for ATTR Market Share by Application: 2025 & 2032
Figure 9. Hospital and Clinic
Figure 10. Retail Pharmacies
Figure 11. Other
Figure 12. Global Antisense Oligonucleotides Drugs for ATTR Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Antisense Oligonucleotides Drugs for ATTR Market Size (US$ Million), 2021–2032
Figure 14. Global Antisense Oligonucleotides Drugs for ATTR Sales (K Units), 2021–2032
Figure 15. Global Antisense Oligonucleotides Drugs for ATTR Average Price (US$/Unit), 2021–2032
Figure 16. Antisense Oligonucleotides Drugs for ATTR Report Years Considered
Figure 17. Antisense Oligonucleotides Drugs for ATTR Sales Share by Manufacturers in 2025
Figure 18. Global Antisense Oligonucleotides Drugs for ATTR Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Antisense Oligonucleotides Drugs for ATTR Players: Market Share by Revenue in Antisense Oligonucleotides Drugs for ATTR in 2025
Figure 20. Antisense Oligonucleotides Drugs for ATTR Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Antisense Oligonucleotides Drugs for ATTR Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Country (2021–2032)
Figure 23. North America Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Country (2021–2032)
Figure 24. United States Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Country (2021–2032)
Figure 27. Europe Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Country (2021–2032)
Figure 28. Germany Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Region (2021–2032)
Figure 35. China Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Country (2021–2032)
Figure 43. Latin America Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Antisense Oligonucleotides Drugs for ATTR by Type (2021–2032)
Figure 54. Global Revenue Market Share of Antisense Oligonucleotides Drugs for ATTR by Type (2021–2032)
Figure 55. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Antisense Oligonucleotides Drugs for ATTR by Application (2021–2032)
Figure 57. Global Revenue Market Share of Antisense Oligonucleotides Drugs for ATTR by Application (2021–2032)
Figure 58. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Application (2021–2032)
Figure 59. Antisense Oligonucleotides Drugs for ATTR Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Antisense Oligonucleotides Drugs for ATTR Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Antisense Oligonucleotides Drugs for ATTR Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Antisense Oligonucleotides Drugs for ATTR Market Competitive Situation by Manufacturers in 2025
Table 4. Global Antisense Oligonucleotides Drugs for ATTR Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Antisense Oligonucleotides Drugs for ATTR Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Antisense Oligonucleotides Drugs for ATTR Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Antisense Oligonucleotides Drugs for ATTR Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Antisense Oligonucleotides Drugs for ATTR, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Antisense Oligonucleotides Drugs for ATTR, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Antisense Oligonucleotides Drugs for ATTR, Product Types and Applications
Table 12. Global Key Manufacturers of Antisense Oligonucleotides Drugs for ATTR, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antisense Oligonucleotides Drugs for ATTR Companies by Tier (Tier 1, Tier 2, Tier 3), based on Antisense Oligonucleotides Drugs for ATTR Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antisense Oligonucleotides Drugs for ATTR Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Antisense Oligonucleotides Drugs for ATTR Sales by Region (K Units), 2021–2026
Table 18. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Region (2021–2026)
Table 19. Global Antisense Oligonucleotides Drugs for ATTR Sales by Region (K Units), 2027–2032
Table 20. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Region (2027–2032)
Table 21. Global Antisense Oligonucleotides Drugs for ATTR Revenue by Region (US$ Million), 2021–2026
Table 22. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Region (2021–2026)
Table 23. Global Antisense Oligonucleotides Drugs for ATTR Revenue by Region (US$ Million), 2027–2032
Table 24. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Region (2027–2032)
Table 25. North America Antisense Oligonucleotides Drugs for ATTR Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2021–2026
Table 27. North America Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2027–2032
Table 28. North America Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2021–2026
Table 29. North America Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Antisense Oligonucleotides Drugs for ATTR Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2021–2026
Table 32. Europe Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2027–2032
Table 33. Europe Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Antisense Oligonucleotides Drugs for ATTR Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2021–2026
Table 42. Latin America Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2027–2032
Table 43. Latin America Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Revenue by Country (US$ Million), 2027–2032
Table 50. Global Antisense Oligonucleotides Drugs for ATTR Sales (K Units) by Type (2021–2026)
Table 51. Global Antisense Oligonucleotides Drugs for ATTR Sales (K Units) by Type (2027–2032)
Table 52. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Type (2021–2026)
Table 53. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Type (2027–2032)
Table 54. Global Antisense Oligonucleotides Drugs for ATTR Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Antisense Oligonucleotides Drugs for ATTR Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Type (2021–2026)
Table 57. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Type (2027–2032)
Table 58. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Type (2021–2026)
Table 59. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Type (2027–2032)
Table 60. Global Antisense Oligonucleotides Drugs for ATTR Sales (K Units) by Application (2021–2026)
Table 61. Global Antisense Oligonucleotides Drugs for ATTR Sales (K Units) by Application (2027–2032)
Table 62. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Application (2021–2026)
Table 63. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Application (2027–2032)
Table 64. Global Antisense Oligonucleotides Drugs for ATTR Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Antisense Oligonucleotides Drugs for ATTR Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Application (2021–2026)
Table 67. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Application (2027–2032)
Table 68. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Application (2021–2026)
Table 69. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Application (2027–2032)
Table 70. Akcea Therapeutics Company Information
Table 71. Akcea Therapeutics Description and Business Overview
Table 72. Akcea Therapeutics Antisense Oligonucleotides Drugs for ATTR Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Akcea Therapeutics Antisense Oligonucleotides Drugs for ATTR Product
Table 74. Akcea Therapeutics Recent Developments/Updates
Table 75. AstraZeneca Company Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Antisense Oligonucleotides Drugs for ATTR Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. AstraZeneca Antisense Oligonucleotides Drugs for ATTR Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Ionis Pharmaceuticals Company Information
Table 81. Ionis Pharmaceuticals Description and Business Overview
Table 82. Ionis Pharmaceuticals Antisense Oligonucleotides Drugs for ATTR Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Ionis Pharmaceuticals Antisense Oligonucleotides Drugs for ATTR Product
Table 84. Ionis Pharmaceuticals Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Antisense Oligonucleotides Drugs for ATTR Distributors List
Table 88. Antisense Oligonucleotides Drugs for ATTR Customers List
Table 89. Antisense Oligonucleotides Drugs for ATTR Market Trends
Table 90. Antisense Oligonucleotides Drugs for ATTR Market Drivers
Table 91. Antisense Oligonucleotides Drugs for ATTR Market Challenges
Table 92. Antisense Oligonucleotides Drugs for ATTR Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Product Picture of Antisense Oligonucleotides Drugs for ATTR
Figure 2. Global Antisense Oligonucleotides Drugs for ATTR Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Antisense Oligonucleotides Drugs for ATTR Market Share by Type: 2025 & 2032
Figure 4. Inotersen Product Picture
Figure 5. Eplontersen Product Picture
Figure 6. Other Product Picture
Figure 7. Global Antisense Oligonucleotides Drugs for ATTR Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Antisense Oligonucleotides Drugs for ATTR Market Share by Application: 2025 & 2032
Figure 9. Hospital and Clinic
Figure 10. Retail Pharmacies
Figure 11. Other
Figure 12. Global Antisense Oligonucleotides Drugs for ATTR Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Antisense Oligonucleotides Drugs for ATTR Market Size (US$ Million), 2021–2032
Figure 14. Global Antisense Oligonucleotides Drugs for ATTR Sales (K Units), 2021–2032
Figure 15. Global Antisense Oligonucleotides Drugs for ATTR Average Price (US$/Unit), 2021–2032
Figure 16. Antisense Oligonucleotides Drugs for ATTR Report Years Considered
Figure 17. Antisense Oligonucleotides Drugs for ATTR Sales Share by Manufacturers in 2025
Figure 18. Global Antisense Oligonucleotides Drugs for ATTR Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Antisense Oligonucleotides Drugs for ATTR Players: Market Share by Revenue in Antisense Oligonucleotides Drugs for ATTR in 2025
Figure 20. Antisense Oligonucleotides Drugs for ATTR Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Antisense Oligonucleotides Drugs for ATTR Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Country (2021–2032)
Figure 23. North America Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Country (2021–2032)
Figure 24. United States Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Country (2021–2032)
Figure 27. Europe Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Country (2021–2032)
Figure 28. Germany Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Region (2021–2032)
Figure 35. China Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Country (2021–2032)
Figure 43. Latin America Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Antisense Oligonucleotides Drugs for ATTR by Type (2021–2032)
Figure 54. Global Revenue Market Share of Antisense Oligonucleotides Drugs for ATTR by Type (2021–2032)
Figure 55. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Antisense Oligonucleotides Drugs for ATTR by Application (2021–2032)
Figure 57. Global Revenue Market Share of Antisense Oligonucleotides Drugs for ATTR by Application (2021–2032)
Figure 58. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Application (2021–2032)
Figure 59. Antisense Oligonucleotides Drugs for ATTR Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232